Literature DB >> 32267079

An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines.

Nicholas M Selby1,2, Maarten W Taal1,2.   

Abstract

Diabetic nephropathy (DN) is a major healthcare challenge. It occurs in up to 50% of those living with diabetes, is a major cause of end-stage kidney disease (ESKD) that requires treatment with dialysis or renal transplantation, and is associated with significantly increased cardiovascular morbidity and mortality. DN is a clinical syndrome characterized by persistent albuminuria and a progressive decline in renal function, but it is increasingly recognized that the presentation and clinical course of kidney disease in diabetes is heterogeneous. The term diabetic kidney disease (DKD) is now commonly used to encompass the spectrum of people with diabetes who have either albuminuria or reductions in renal function. In this article, the clinical presentation and approach to diagnosis of DKD will be discussed, as will its prognosis. The general principles of management of DKD will also be reviewed with reference to current international guidelines.
© 2020 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32267079     DOI: 10.1111/dom.14007

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  47 in total

1.  Interference of S100A16 suppresses lipid accumulation and inflammation in high glucose-induced HK-2 cells.

Authors:  Lanlan Liu; Shan Lan
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

Review 2.  Role of Zinc in Diabetic Kidney Disease.

Authors:  Guido Gembillo; Luca Visconti; Alfio Edoardo Giuffrida; Vincenzo Labbozzetta; Luigi Peritore; Antonella Lipari; Vincenzo Calabrese; Giorgina Barbara Piccoli; Massimo Torreggiani; Rossella Siligato; Domenico Santoro
Journal:  Nutrients       Date:  2022-03-24       Impact factor: 5.717

3.  [Exploring the therapeutic mechanism of Longqi Fang for diabetic kidney disease based on network pharmacology and verification in rats].

Authors:  L Xing; W Xing; H Guo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

4.  Short chain fatty acids for the risk of diabetic nephropathy in type 2 diabetes patients.

Authors:  Yang Li; Guo-Qiang Qin; Wan-Ying Wang; Xu Liu; Xiao-Qian Gao; Jun-Hui Liu; Tao Zheng; Wei Zhang; Lan Cheng; Kun Yang; Xin You; Yue Wu; Zhong-Ze Fang
Journal:  Acta Diabetol       Date:  2022-04-03       Impact factor: 4.280

5.  The promising significance of liraglutide combined with dapagliflozin or empagliflozin in the prevention of early diabetic nephropathy.

Authors:  Qin Li; Xing Wang; Aili Guo; Wenxia Zheng; Jin Bi; Yan He; Qiong Luo
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

6.  Effects of Metformin on Renal Function, Cardiac Function, and Inflammatory Response in Diabetic Nephropathy and Its Protective Mechanism.

Authors:  Zhiping Zhang; Hongyu Dong; Jiaqi Chen; Min Yin; Feng Liu
Journal:  Dis Markers       Date:  2022-06-03       Impact factor: 3.464

7.  Screening and Identification of Hub Genes in the Development of Early Diabetic Kidney Disease Based on Weighted Gene Co-Expression Network Analysis.

Authors:  Ran Wei; Jingtao Qiao; Di Cui; Qi Pan; Lixin Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

8.  NMR-Based Metabolomics in Differential Diagnosis of Chronic Kidney Disease (CKD) Subtypes.

Authors:  Styliani A Chasapi; Evdokia Karagkouni; Dimitra Kalavrizioti; Sotirios Vamvakas; Aikaterini Zompra; Panteleimon G Takis; Dimitrios S Goumenos; Georgios A Spyroulias
Journal:  Metabolites       Date:  2022-05-28

9.  Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study.

Authors:  Su Jin Jeong; Seung Eun Lee; Dong Hyun Shin; Ie Byung Park; Hui Seung Lee; Kyoung-Ah Kim
Journal:  BMC Nephrol       Date:  2021-05-14       Impact factor: 2.388

Review 10.  Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.

Authors:  Nur Samsu
Journal:  Biomed Res Int       Date:  2021-07-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.